A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

被引:0
|
作者
Mark, Tomer M. [1 ]
Reid, Whitney [1 ]
Niesvizky, Ruben
Gergis, Usama [2 ]
Pearse, Roger N.
Mayer, Sebastian [1 ]
Coleman, Morton [1 ]
Feldman, Eric J. [2 ]
Shore, Tsiporah B. [1 ]
机构
[1] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA
[2] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:895 / 895
页数:1
相关论文
共 50 条
  • [1] A PHASE I STUDY OF BENDAMUSTINE AND MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA
    Mark, T. M.
    Niesvizky, R.
    Gergis, U.
    Pearse, R. N.
    Mayer, S.
    Feldman, E. J.
    Shore, T. B.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S199 - S199
  • [2] A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplantation in Multiple Myeloma
    Mark, Tomer M.
    Reid, Whitney
    Niesvizky, Ruben
    Gergis, Usama
    Pearse, Roger
    Mayer, Sebastian
    Greenberg, June
    Coleman, Morton
    Van Besien, Koen
    Shore, Tsiporah
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 831 - 837
  • [3] A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger
    Phillips, Adrienne A.
    Rossi, Adriana C.
    Coleman, Morton
    Van Besien, Koen
    Shore, Tsiporah B.
    [J]. BLOOD, 2017, 130
  • [4] Mitoxantrone and melphalan as conditioning regimen for autologous stem cell transplant for multiple myeloma.
    Beaven, Anne W.
    Comeau, Terrance
    Sharf, Andrew
    Moore, Dominic T.
    Serody, Jonathan
    Shea, Thomas C.
    Gabriel, Don A.
    [J]. BLOOD, 2006, 108 (11) : 834A - 834A
  • [5] A Conditioning Regimen of Bendamustine and Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma: A Phase 2, Single-Arm, Prospective Study
    Zeng, Qiang
    Li, Jian
    Dong, Tian
    Chen, Xinchuan
    Kuang, Pu
    Niu, Ting
    Ji, Jie
    Liu, Zhigang
    Liu, Ting
    [J]. BLOOD, 2023, 142
  • [6] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    [J]. Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [7] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [8] Bendamustine, Carfilzomib, and Melphalan (BCM) Conditioning Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Feasibility Study
    Al-Homsi, A. Samer
    Muilenburg, Marlee
    Cole, Kelli
    Abidi, Muneer H.
    Williams, Stephanie F.
    [J]. BLOOD, 2016, 128 (22)
  • [9] A phase II study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy
    Martino, M.
    Fedele, R.
    Moscato, T.
    Console, G.
    Vincelli, I. D.
    Irrera, G.
    Gentile, M.
    Morabito, F.
    Messina, G.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S20 - S20
  • [10] A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy
    Martino, Massimo
    Giuseppe, Messina
    Fedele, Roberta
    Irrera, Giuseppe
    Giuseppe, Console
    Gallo, Giuseppe Alberto
    Vincelli, Iolanda Donatella
    Ronco, Francesca
    Gentile, Massimo
    Morabito, Fortunato
    [J]. BLOOD, 2015, 126 (23)